Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation
Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation |
|
https://doi.org/10.18632/oncotarget.27316
Melanie Haas Kucherlapati
|
| 6913-6933 |
Analog-sensitive cell line identifies cellular substrates of CDK9
Analog-sensitive cell line identifies cellular substrates of CDK9 |
|
https://doi.org/10.18632/oncotarget.27334
Tim-Michael Decker,
Ignasi Forné,
Tobias Straub,
Hesham Elsaman,
Guoli Ma,
Nilay Shah,
Axel Imhof,
and Dirk Eick
|
| 6934-6943 |
The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo
The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.27341
Walter Blum,
Thomas Henzi,
László Pecze,
Kim-Long Diep,
Christian G. Bochet,
and Beat Schwaller
|
| 6944-6956 |
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments |
|
https://doi.org/10.18632/oncotarget.27343
Antonio Marchetti,
Alessia Di Lorito,
Lara Felicioni,
and Fiamma Buttitta
|
| 6957-6968 |
Flow cytometric significance of cellular alkaline phosphatase activity in acute myeloid leukemia
Flow cytometric significance of cellular alkaline phosphatase activity in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.27356
Laura G. Rico,
Jordi Juncà,
Michael D. Ward,
Jolene A. Bradford,
and Jordi Petriz
|
| 6969-6980 |
Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27363
Irem Durmaz Sahin,
Jenny-Maria Jönsson,
and Ingrid Hedenfalk
|
| 6981-6996 |
p53-inducible SESTRINs might play opposite roles in the regulation of early and late stages of lung carcinogenesis
p53-inducible SESTRINs might play opposite roles in the regulation of early and late stages of lung carcinogenesis |
|
https://doi.org/10.18632/oncotarget.27367
Boxiao Ding,
Alexander Haidurov,
Ayesha Chawla,
Anita Parmigiani,
Gerarda van de Kamp,
Alexandra Dalina,
Fang Yuan,
Jun Hee Lee,
Peter M. Chumakov,
Steven R. Grossman,
and Andrei V. Budanov
|
| 6997-7009 |
Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma |
|
https://doi.org/10.18632/oncotarget.27350
Jingyu Zhu,
Man Wang,
Yang Yu,
Huixin Qi,
Kunkun Han,
Juan Tang,
Zubin Zhang,
Yuanying Zeng,
Biyin Cao,
Chunhua Qiao,
Hongjian Zhang,
Tingjun Hou,
and Xinliang Mao
|
| 7010-7011 |
Correction: Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells
Correction: Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.27352
Vladimir N. Ivanov,
Jinhua Wu,
Tony J.C. Wang,
and Tom K. Hei
|
| 7012-7013 |
Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells
Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.27353
Ming Zhao,
Ming-Lei Zhuo,
Xiaofeng Zheng,
Xiaoping Su,
and Funda Meric-Bernstam
|
| 7014-7015 |
